Company profile
Elixira company profile
Elixira is open for licensing partnerships. Invented and founded by Tess Fries, Elixira is a patent-pending, AI-guided nanobot platform designed as a one-time injection for lifelong, autonomous prevention across all cancer types. Its technical feasibility has been independently reviewed by a world-leading European Contract Research Organization (CRO), and all core technologies underlying Elixira are based on validated and peer-referenced scientific principles. A detailed technical feasibility report is available to prospective partners under NDA. Developed on in vivo–proven nanotechnology and biomedical-engineering foundations, Elixira integrates self-sustaining hybrid-energy systems and multiple elimination methods to enable a proactive, continuous prevention model. Operating autonomously inside..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://elixira.tech/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2025-07-03
Headquarters
- Headquarters
- Lund, Skane Lan, Sweden
- Postal code
- 22476
- Country code
- SE
- Continent
- Europe